Test Price
2,800 AEDโ Home Collection Available
BMPR1A Gene Juvenile Polyposis Syndrome Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (available daily 8 AM โ 11 PM)
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by Consultant Medical Genetics
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
- Price: 2,800 AED | Turnaround Time: 3โ4 Weeks
Test Overview & Methodology
This genetic test uses full-gene Next Generation Sequencing (NGS) of the BMPR1A coding region, splice sites, and deep intronic regions to detect mutations causing Juvenile Polyposis Syndrome (JPS). Results enable precise risk assessment for colorectal cancer and guide lifelong surveillance planning.
| Feature | Our Test (BMPR1A NGS) | Closest Alternative |
|---|---|---|
| Methodology | Full-Gene NGS (Next Generation Sequencing) | Targeted PCR/Sanger (limited exons) |
| Turnaround Time | 3 โ 4 Weeks | 4 โ 6 Weeks |
| Price (AED) | 2800 | ~2500 (incomplete coverage) |
| Regulatory Compliance | DHA/MOHAP Licensed, ISO 9001:2015, UAE PDPL | Variable |
| Comprehensiveness | All coding regions, splice sites & deep intronic regions | Selected hot-spots only |
Physician Insight & Safety Protocols
โAs a Consultant Medical Genetics, I understand the profound implications of hereditary cancer testing. This full-gene BMPR1A NGS analysis empowers patients and families with actionable knowledge about Juvenile Polyposis Syndrome. A positive result is not a cancer diagnosis โ it is a roadmap for surveillance, early detection, and prevention. Genetic counselling is an integral part of this journey.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory โ Medication & Clinical Context
Do not discontinue prescribed medication without consulting your doctor. Genetic test results do not replace ongoing clinical care. Always share your genetic report with your primary care provider for integrated management.
Exclusion Criteria & Emergency Red Flags
- This test is not suitable for patients currently hospitalised with acute gastrointestinal bleeding without prior stabilisation.
- Genetic counselling session is mandatory before sample collection; failure to complete may delay reporting.
- If you experience sudden severe abdominal pain, profuse rectal bleeding, or signs of intestinal obstruction, seek emergency medical care immediately. Do not wait for test results.
- For minors, written consent from a legal guardian is required in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What is the BMPR1A gene and Juvenile Polyposis Syndrome?
Answer: BMPR1A gene mutations cause Juvenile Polyposis Syndrome (JPS), a hereditary condition characterised by multiple gastrointestinal polyps that elevate the risk of colorectal cancer. Our NGS test detects mutations across the entire coding region, splice junctions, and deep intronic areas, enabling personalised surveillance strategies.
2. Who should consider this genetic test?
Answer: Individuals with multiple juvenile polyps, a family history of JPS or early-onset colorectal cancer, and those with suspected hereditary polyposis should consider BMPR1A testing after pre-test genetic counselling. It is also recommended for asymptomatic individuals with a known family mutation.
3. How accurate is the NGS test for BMPR1A?
Answer: With 99.9% analytical sensitivity and specificity, our full-gene NGS detects single nucleotide variants, small insertions/deletions, and copy number changes in BMPR1A with clinical-grade precision. Validation includes orthogonal methods (Sanger sequencing and MLPA) for ambiguous results.
4. What sample types are accepted and how is collection managed?
Answer: Acceptable specimens include peripheral whole blood (EDTA), extracted DNA, or one drop of blood on an FTA card. Collection is performed via VIP Mobile Phlebotomy at your home (8 AM โ 11 PM daily) using temperature-controlled cold-chain logistics. No hospital visit required for standard blood draws.
UAE Regulatory & Data Privacy Adherence
Data Protection & Healthcare Compliance:
- Your genetic data is processed under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Informed consent and medical liability are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
- DNA Labs UAE is ISO 9001:2015 certified (INT/EGQ/2509DA/3139) and holds DHA Facility License No. 1143.
- All results are delivered via secure, encrypted channels with strict access controls.
Clinical & Logistical Metadata
| Test Name | BMPR1A Gene Full-Gene NGS โ Juvenile Polyposis Syndrome |
| Price (AED) | 2,800 |
| Turnaround Time | 3 โ 4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA), extracted DNA, or FTA card blood spot |
| Methodology Used | Next Generation Sequencing (NGS) โ full coding region, splice sites, deep intronic regions |
| ICD-10-CM Code | Q85.09 (Juvenile polyposis syndrome) |
| LOINC Code | 21636-6 (BMPR1A gene mutation analysis in Blood or Tissue by Sequencing) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians